The Future Directions of Lupus Research is a planning document presented by the National Institutes of Health (NIH) and developed with tremendous input from scientific experts from the lupus research community and beyond. This document focuses on five major areas of research including: disease etiology; innate immunity, acquired immunity and inflammation; target organ damage; pediatric lupus, special populations and health services research; and diagnosis and treatment.
NIAMS Community Health Clinic Updated May 2, 2016 About the NIAMS Community Health Clinic What is the NIAMS Community Health Clinic? Where is the health clinic located? What types of patient care services are available at the health clinic? What kinds of health information and education programs are available at
Formed in 2005, the NIH AI/AN Health Communications and Information Work Group provides a forum for health education and communications staff from National Institutes of Health (NIH) Institutes, Centers, and Offices to share strategies and effective communication approaches to develop and disseminate health information to American Indian and Alaska Native
Dr. Bhattacharyya is a physician in the NIAMS Orthopedic Unit. His research involves studying and analyzing orthopedic outcomes.
What is acne? Acne is a common skin condition that happens when hair follicles under the skin become clogged. Oil and dead skin cells plug the pores, and outbreaks of lesions (often called pimples or zits) can happen. Most often, the outbreaks occur on the face but can also appear on the back, chest, and shoulders. For most people, acne tends to go away by the time they reach their thirties, but some people in their forties and fifties continue to have this skin problem.
Dr. O’Shea is Scientific Director of the NIAMS and Director of the Intramural Research Program. He is Chief of the Molecular Immunology and Inflammation Branch and studies cytokine signaling transduction.
File Type Name of Viewer Download Link pdf Adobe Reader Download from Adobe mp3 Microsoft Windows Media Player Download from Microsoft
NIAMS reserves the right to monitor all postings to its social media pages. Individuals commenting in their official capacity on any platform must identify their Agency relationship. Comments that contain the following will be deleted: Political endorsements of parties, candidates, or groups. Commercial endorsements of products, services, organizations, or other
The FOIA, 5 U.S.C. 552, provides individuals with a right to access to records in the possession of the Federal government. The government may withhold information pursuant to the nine exemptions and three exclusions contained in the Act. If you have questions regarding FOIA requests pending with the National Institute
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) is making every effort to ensure that the information available on our website is accessible to all. If you use special adaptive equipment to access the Web and encounter problems when using
Information on this site The text you find on this site is in the public domain. You may use and reproduce text material you find on this website. Many of the photographs appearing on this website have been purchased from other sources and are copyrighted. The NIAMS cannot grant anyone
February 2011 (historical) Organization Chart View a larger version of the organization chart. Top Appropriation Language NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and title IV of the Public Health Services Act with respect to arthritis and musculoskeletal and
June 8, 2012 (historical) The decision to fund or not to fund a particular application is based on the assessment of scientific merit by a peer review group and on the relevance of the proposed work to the Institute's scientific and health priorities. Peer reviewers' judgments of scientific merit are
U.S. Department of Health and Human Services National Institutes of Health Agenda 108th Meeting National Arthritis and Musculoskeletal and Skin Diseases Advisory Council Lindsey A. Criswell, M.D., M.P.H., D.Sc., Chair National Institutes of Health Virtual Meeting via Zoom Tuesday, June 7th, 2022 – 10:00 AM – OPEN TO THE PUBLIC
The NIAMS has determined that investigator-initiated, interventional clinical trials requesting NIAMS support should undergo a rigorous planning, design, and documentation phase before a decision is made to implement a study with a substantial fiscal and human resource investment. The implementation of a clinical trial requires extensive administrative planning (e.g., protocol
Following the completion of designated milestones in the clinical trial planning process, investigators may consider applying for a Clinical Trial Implementation Cooperative Agreement (U01). The NIAMS will only accept, peer review, and consider funding applications for implementation of investigator-initiated clinical trials when the necessary planning and administrative tasks have been
The primary objective of the Centers of Research Translation (CORT) (P50) Program is to foster research that is translational in nature, directed at elucidating the relevance of basic research to human disease in an area within the NIAMS mission. Two major features of the CORT program include: 1) the overarching
The following are commonly asked questions and their answers about what happens after submitting a grant application and who to contact before and after the scientific review of the application.
The NIAMS recognizes that planning and administrative activities for starting a trial can vary based on the type of study being conducted. For example, regulatory approvals for a Phase III multi-site study of a new therapeutic agent will differ from a trial of a behavioral intervention or a device. The